| 2001P-0075 - Switch Status of Emergency Contraceptives from Rx to OTC | |||||||||||||||||||||||
| FDA Comment Number : | EC762 | ||||||||||||||||||||||
| Submitter : | Dr. Margaret Moloney | Date & Time: | 05/14/2004 06:05:20 | ||||||||||||||||||||
| Organization : | Emory University | ||||||||||||||||||||||
| Health Professional | |||||||||||||||||||||||
| Category : | |||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| As a nurse practitioner, I have cared for numerous women who have needed Plan B. I have never seen any adverse effects; this is supported by both research and clinical practice.
I urge you to make Plan B available over the counter to women. This drug is a vital tool to provide backup contraception for those women whose primary contraception fails. | |||||||||||||||||||||||